These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Recent news in the treatment of lupus nephritis. Tesar V; Hruskova Z Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617 [TBL] [Abstract][Full Text] [Related]
8. Rituximab, a viable alternative for induction therapy of active lupus nephritis. Zhou XJ; Zhao MH; Zhang H Rheumatology (Oxford); 2014 Sep; 53(9):1537-8. PubMed ID: 24729446 [No Abstract] [Full Text] [Related]
9. Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen. Tedeschi B; Arnaud L; Hie M; Mathian A; Amoura Z Ann Rheum Dis; 2014 Feb; 73(2):474-5. PubMed ID: 24001887 [No Abstract] [Full Text] [Related]
10. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence. Navaneethan SD; Viswanathan G; Strippoli GF Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001 [TBL] [Abstract][Full Text] [Related]
11. Recent progress in the treatment of lupus nephritis. Fanouriakis A; Krasoudaki E; Tzanakakis M; Boumpas DT Mod Rheumatol; 2012 Nov; 22(6):803-13. PubMed ID: 22584472 [TBL] [Abstract][Full Text] [Related]
12. Anti-CD20 antibody treatment in refractory Class IV lupus nephritis. Carroll RP; Brown F; Kerr PG Nephrol Dial Transplant; 2007 Jan; 22(1):291-3. PubMed ID: 17095581 [No Abstract] [Full Text] [Related]
13. [Treatment of systemic lupus erythematosus: myths, certainties and doubts]. Ruiz-Irastorza G; Danza A; Khamashta M Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892 [TBL] [Abstract][Full Text] [Related]
14. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials. Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601 [TBL] [Abstract][Full Text] [Related]
15. New and future therapies for lupus nephritis. Appel GB Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564 [TBL] [Abstract][Full Text] [Related]
16. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis. Marks SD; Tullus K Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881 [TBL] [Abstract][Full Text] [Related]
17. Current and novel therapeutics in the treatment of systemic lupus erythematosus. Yildirim-Toruner C; Diamond B J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study. Rovin BH; Furie R; Latinis K; Looney RJ; Fervenza FC; Sanchez-Guerrero J; Maciuca R; Zhang D; Garg JP; Brunetta P; Appel G; Arthritis Rheum; 2012 Apr; 64(4):1215-26. PubMed ID: 22231479 [TBL] [Abstract][Full Text] [Related]